The discovery, which combines innovative synthetic chemistry and cutting-edge mechanistic studies in molecular biology, offers a potentially powerful new approach to treating drug-resistant glioma tumors that form in the brain and spinal cord. “A major problem in treating gliomas is that patients can rapidly develop resistance to the drug temozolomide, which has been the backbone of...